These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16257375)

  • 1. The rational design of vaccines.
    Bramwell VW; Perrie Y
    Drug Discov Today; 2005 Nov; 10(22):1527-34. PubMed ID: 16257375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing vaccine effectiveness with delivery technology.
    Beitelshees M; Li Y; Pfeifer BA
    Curr Opin Biotechnol; 2016 Dec; 42():24-29. PubMed ID: 26954947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systems framework for vaccine design.
    Mooney M; McWeeney S; Canderan G; Sékaly RP
    Curr Opin Immunol; 2013 Oct; 25(5):551-5. PubMed ID: 24358511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery.
    Griffin JF
    Adv Drug Deliv Rev; 2002 Oct; 54(6):851-61. PubMed ID: 12363434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal vaccine delivery systems.
    Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
    Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery.
    Gause KT; Wheatley AK; Cui J; Yan Y; Kent SJ; Caruso F
    ACS Nano; 2017 Jan; 11(1):54-68. PubMed ID: 28075558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-associated lymphoid tissues for the development of oral vaccines.
    Kunisawa J; Kurashima Y; Kiyono H
    Adv Drug Deliv Rev; 2012 May; 64(6):523-30. PubMed ID: 21827802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and challenges in vaccine delivery.
    Carstens MG
    Eur J Pharm Sci; 2009 Mar; 36(4-5):605-8. PubMed ID: 19063966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting vaccines to dendritic cells.
    Foged C; Sundblad A; Hovgaard L
    Pharm Res; 2002 Mar; 19(3):229-38. PubMed ID: 11934227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designer outer membrane vesicles as immunomodulatory systems - Reprogramming bacteria for vaccine delivery.
    Gnopo YMD; Watkins HC; Stevenson TC; DeLisa MP; Putnam D
    Adv Drug Deliv Rev; 2017 May; 114():132-142. PubMed ID: 28501509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design opportunities for actively targeted nanoparticle vaccines.
    Fahmy TM; Demento SL; Caplan MJ; Mellman I; Saltzman WM
    Nanomedicine (Lond); 2008 Jun; 3(3):343-55. PubMed ID: 18510429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the lymphatic system in vaccine trafficking and immune response.
    Pal I; Ramsey JD
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):909-22. PubMed ID: 21683103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of nasal vaccines.
    Slütter B; Hagenaars N; Jiskoot W
    J Drug Target; 2008 Jan; 16(1):1-17. PubMed ID: 18172815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 1.
    Jones SD
    IDrugs; 2010 Oct; 13(10):689-91. PubMed ID: 20878588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vaccine delivery--new strategies and technologies.
    Simerska P; Moyle PM; Olive C; Toth I
    Curr Drug Deliv; 2009 Aug; 6(4):347-58. PubMed ID: 19534712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloidal drug delivery systems in vaccine delivery.
    Beg S; Samad A; Nazish I; Sultana R; Rahman M; Ahmad MZ; Akbar M
    Curr Drug Targets; 2013 Jan; 14(1):123-37. PubMed ID: 23072326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambiguities in the preclinical quality assessment of microparticulate vaccines.
    Johansen P; Gander B; Merkle HP; Sesardic D
    Trends Biotechnol; 2000 May; 18(5):203-11. PubMed ID: 10758515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in vaccine adjuvants.
    Singh M; O'Hagan DT
    Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery systems and adjuvants for oral vaccines.
    Lavelle EC; O'Hagan DT
    Expert Opin Drug Deliv; 2006 Nov; 3(6):747-62. PubMed ID: 17076597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design.
    Handel A; Li Y; McKay B; Pawelek KA; Zarnitsyna V; Antia R
    PLoS Comput Biol; 2018 Oct; 14(10):e1006505. PubMed ID: 30273336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.